Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance.
This NICE technology appraisal guidance considers the clinical and cost effectiveness of the use of alteplase for acute ischaemic stroke.
Chung
H
H
National Institute for Health and Clinical Excellence, UK.
Refoios Camejo
R
R
Camejo
R R
RR
Barnett
D
D
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D017410:Practice Guidelines as Topic; D020521:Stroke / Q000188:drug therapy*; D013673:Technology Assessment, Biomedical; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator